Gossamer Bio is moving toward acquiring Respira Therapeutics and its lead treatment candidate, RT234, an inhaled therapy being…
Articles by Lindsey Shapiro, PhD
The European Patent Office has given Tenax Therapeutics notice that it plans to grant a patent covering the use…
The degree of tricuspid regurgitation (TR), a cardiac abnormality detected in a heart ultrasound, may help predict the outcomes in…
Among U.S. healthcare providers who treat pulmonary arterial hypertension (PAH), a patient’s current treatment, PAH cause, and coexisting health…
Balloon pulmonary angioplasty (BPA) led to significant clinical improvements for people with chronic thromboembolic pulmonary hypertension (CTEPH) when used…
The U.S. Food and Drug Administration (FDA) has approved Yutrepia, Liquidia’s inhaled dry powder formulation of treprostinil, for improving…
The first patient has been enrolled in a pivotal study testing the accuracy of Sensydia’s noninvasive Cardiac Performance System…
On May 5, more than 80 organizations around the world will join to raise awareness of pulmonary hypertension (PH),…
A higher diameter and a faster enlargement rate of the body’s main pulmonary artery — dubbed the MPA, it carries…
Researchers in the U.S. have developed a tool to help predict mortality risk in people with chronic lung disease and…
Corsair Pharma successfully completed preclinical studies testing its skin patch delivery system for treprostinil as a treatment for…
The National Organization for Rare Disorders (NORD) is seeking participants for its survey-based study Living Rare, which aims to…